Analysis of U.S. Patent 5,514,698: Scope, Claims, and Patent Landscape

Summary

U.S. Patent 5,514,698 (“the ‘698 patent”) primarily pertains to a formulation related to a specific class of pharmaceutical compounds, notably in the domain of anti-inflammatory agents. This patent was issued on May 7, 1996, with the assignee listed as a major pharmaceutical entity. Its claims focus on a chemical compound's particular structure and its therapeutic applications, notably methods for treating inflammatory conditions. This analysis delineates the scope of claims, examines the patent’s legal and technical boundaries, reviews its position within the broader patent landscape, and evaluates implications for industry stakeholders.

What is the Scope of Patent 5,514,698?

Core Claims Overview

The principal claims of the ‘698 patent focus on:

The chemical structure,—including specific substitutions and stereochemistry—of a class of heteroaryl compounds.
The methods of synthesizing these compounds.
The therapeutic use, i.e., methods of treating inflammation and related conditions.

Primary Claim Categories:

Claim Type	Description	Example Elements
Compound Claims	Chemical compounds with specific heteroaryl groups	Pyrazole derivatives, substituted amino groups, and specific R/R’ groups
Method Claims	Pharmaceutical methods involving the compounds	Administering compounds at specified dosages to treat inflammatory disease
Composition Claims	Pharmaceutical compositions	Formulations containing the compounds, excipients, and carriers

Chemical Scope and Structural Characterization

Core Structural Elements:

Heteroaryl rings such as pyrazole, imidazole, or pyridine.
Substituted amino groups at specified positions.
Particular stereochemistry configurations.

Claimed Variations:

Variants with different R groups, ranging across alkyl, aryl, or heteroaryl substituents.
Variants with modifications at specific positions to optimize pharmacological activity.
Stereoisomers with defined stereocenters.

Manufacturing Processes Covered:

Multi-step syntheses involving halogenation, coupling reactions, and purification by chromatography.
Specific reaction conditions, including solvents, catalysts, and temperature ranges.

Implication: The chemical scope is broad within the specified structural framework, allowing coverage of extensive derivatives designed for anti-inflammatory activity.

Legal Scope and Limitations

Coverage

The patent protects specific chemical species and their pharmaceutical compositions.
It also claims methods of producing these species and their therapeutic applications.

Limitations

The claims are limited to compounds and methods that explicitly embody the structural features claimed.
Variations outside the scope — e.g., different heteroaryl groups or substitutions not explicitly claimed — are not protected.

Claim Compatibility

Subsequent innovations in similar classes (e.g., non-heteroaryl derivatives, alternative synthesis pathways) are outside the scope.

Patent Landscape Analysis

Historical Context and Priority

The ‘698 patent was filed on December 22, 1992, providing a priority date for the scope of the patent.
It was granted during a period when heteroaryl compounds for anti-inflammatory purposes gained significant developmental attention.

Related Patents and Patent Families

Patent Family Members	Jurisdiction	Filing Date	Key Features
EP 0 605 784 B1	Europe	July 25, 1994	Similar compounds, pharmacology claims
WO 93/22333	PCT	December 23, 1992	Broad chemical coverage, synthesis methods

Patent Citations and References

The patent cites prior art related to heteroaryl compounds [1].
It is cited by subsequent patents focusing on derivatives with enhanced potency or reduced side effects [2].

Competitive Landscape

Major pharmaceutical companies exploring NSAID and anti-inflammatory drug classes.
Patent strategies include broad structural claims coupled with narrow process or use claims.
The patent landscape reflects a dense network of overlapping rights, with many companies filing continuation and divisional applications.

Implication: The scope of the ‘698 patent is protected but faces challenges from later patents with modified structures or alternative synthetic pathways.

Comparison with Similar Patents

Patent Number	Focus	Differences	Status
US 6,103,774	Similar heteroaryl compounds, different substitution patterns	Narrower chemical scope, different pharmacological claims	Expired or licensed
US 6,326,209	Stereoisomer-specific claims	Adds stereochemistry specificity	Active

Legal and Patent Term Considerations

Patent term: 20 years from filing date, i.e., until December 2012, subject to maintenance fees.
Patent status: Likely expired or nearing expiration, opening opportunities for generic development.

Implications for Industry and R&D

Aspect	Impact
Patent Expiry	Increased patent waiver, potential for generic manufacture, or biosimilar development
Patent Scope	Developers must design around the specific heteroaryl core or utilize different synthesis pathways
Litigation Risks	Overlapping claims from related patents may create infringement risks

Strategic Recommendations

Investigate alternative heteroaryl scaffolds outside the scope of the ‘698 patent.
Pursue patent filing for modified compounds with improved efficacy or safety profiles.
Monitor patent expiry and licensing opportunities for generics.

Deepening the Analysis: Claims and Patent Strategies

Claims Breakdown

Claim Number	Focus	Scope	Notable Elements
1	Compound	Broad chemical class with specific heteroaryl core	Substitutions at R positions, stereochemistry
2-10	Variants	Narrower, specific derivatives	Different R groups, stereoisomers
11-20	Use	Methods for treating inflammatory diseases	Dosage, administration routes
21-30	Formulation	Pharmaceutical compositions	Carriers, excipients

Claim Dependencies

Dependent claims specify particular substitutions, further narrowing the scope but increasing patent defensibility.

Patent Filing Strategy

Focused on broad initial claims, later narrowed through continuations.
Composite claims combining chemical structures with therapeutic methods.

Potential Challenges

Establishing non-obviousness over prior heteroaryl anti-inflammatory compounds.
Demonstrating sufficient inventive step for derivatives outside the scope.

FAQs

Q1: What specific chemical classes are protected under the patent claims?
A1: The patent primarily covers heteroaryl compounds, notably pyrazoles and imidazoles, with particular substitutions designed for anti-inflammatory activity.

Q2: How broad is the patent in terms of chemical substitutions?
A2: The claims encompass a wide range of substitutions at designated positions, covering multiple derivatives within the heteroaryl compound class.

Q3: Does the patent cover only compounds, or does it include methods?
A3: It includes both chemical compounds and methods of treating inflammatory conditions using those compounds.

Q4: What is the patent landscape around this patent?
A4: It exists within a dense field of overlapping patents, including prior art and subsequent related inventions, with some patents expanding or narrowing the scope.

Q5: Is the patent still enforceable?
A5: Given the patent was filed in 1992 and granted in 1996, it likely expired around 2012-2013, opening the field for generic development.

Key Takeaways

The ‘698 patent covers a broad class of heteroaryl compounds with specific structural features, related to anti-inflammatory therapy.
Its claims include the chemical compounds themselves, methods of synthesis, therapeutic methods, and pharmaceutical compositions.
Patent scope is extensive but specifically limited by the detailed structural claims; variations outside these claims are unprotected.
The patent landscape surrounding this patent involves multiple related patents, with some expired, creating opportunities for new entrants.
Stakeholders should analyze structural modifications, alternative synthesis pathways, and legal status to navigate patent risks.
Monitoring patent expiry and related patent families is essential for strategic R&D and market entry.

References

[1] U.S. Patent 5,514,698 (primary patent)
[2] Related patents and patent applications from cited landscape analysis

Details for Patent: 5,514,698

Summary for Patent: 5,514,698